Clinical Support and its Ongoing Development
Consistent with the charter of the Bronowski Institute of Behavioural Neuroscience the staff of the Bronowski Clinic is devoted to disseminating their knowledge and experience to improve the quality of life in people with Parkinson’s disease. To achieve this we provide or are developing the following professional support for doctors and clinicians in their clinical practice of treating the disorder.
| 1 |
Provide advice on strategic light use in combination with dopamine replacement. Factors such as time, frequency and duration of treatment as well as crucial drug combinations and total drug burden that patients can tolerate. Critical adjuvant drug therapies and methods for titrating and titrating withdrawal strategies when using light as a parallel treatment.
|
| 2 |
To provide information as to the drugs and doses of drugs which interfere with the therapeutic effect of the light used in photopharmacological approach.
|
| 3 |
To provide advice as to the best management practices for the comorbidities of anxiety, depression and insomnia as a parallel when implementing the photopharmacological approach to treating Parkinson’s disease.
|
| 4 |
To advise as to the features and effects of light overdosing and provide a profile and consequences of light and drug overdosing in sensitive patients.
|
5 |
To provide a strategy for treating drug overdosing phenomena with strategic drug titration withdrawal strategies that will negate the need for invasive forms of surgical intervention.
|
| 6 |
To complete a Clinician’s Manual describing the key elements in using the photopharmacological method to safely and effectively treat Parkinson’s disease and its comorbidities.
|
| 7 |
To provide a description for a long term method for the application of the Photopharmacological approach to slow or stop the progressive degeneration of the disease.
|
Please login for more Clinician resources and information.